Edition:
United States

People: ZELTIQ Aesthetics Inc (ZLTQ.O)

ZLTQ.O on Nasdaq

45.76USD
8 Dec 2016
Change (% chg)

$1.72 (+3.91%)
Prev Close
$44.04
Open
$44.19
Day's High
$46.00
Day's Low
$43.92
Volume
1,133,816
Avg. Vol
791,369
52-wk High
$46.00
52-wk Low
$18.41

Schiff, Andrew 

Dr. Andrew N. Schiff, M.D., is an Independent Director of Zeltiq Aesthetics Inc., since July 2010. Dr. Schiff joined a Aisling Capital in September of 1999 and has served as a Managing Partner since 2002. Prior to joining Aisling Capital, Dr. Schiff practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine. In addition to ZELTIQ, Dr. Schiff currently serves as a Director of ARMGO Pharma, Inc., Colorscience, Dynova Laboratories, Inc., Agile Therapeutics, Inc. and Planet Technologies, Inc. Previously, Dr. Schiff served as a Director of Adams Respiratory Therapeutics, Inc., Barrier Therapeutics, Bioenvision, Inc., Cempra Pharmaceuticals, Inc., CardioKine, Inc., Miramar Laboratories, Inc., Myogen, Inc., SkinMedica, Inc., Sirion Therapeutics, Inc., and TransEnterix, Inc. Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.

Basic Compensation

Total Annual Compensation, USD 57,500
Restricted Stock Awards, USD 174,952
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 232,452

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --